Although focused ultrasound therapy sounds to be a glorious medical breakthrough, it may not as spectacular as Grisham dictates it to be. Following the diagram about the obstacles, Grisham adds, “Additional resources are needed to bridge the gap between research and trials and treating millions of patients with disabling or life-threatening disorders.” (Grisham 42) meaning that although this technique appears to be effective, it is still an early-stage research treatment. Therefore the majority of testing clinical trials remain in the clinical stage not advancing further assuming it may not meet FDA requirements as seen in the diagram on page 40. Insurance companies look through documentation towards the research treatment the patient feels
